文献速递慢性静脉疾病

双作用气压压缩装置与压力袜在慢性静脉疾病中的患者中心结局比较

Patient-centered outcomes of a dual action pneumatic compression device in comparison to compression stockings for patients with chronic venous disease.
PubMed 文献 · J Vasc Surg Venous Lymphat Disord · 2017-01-01

一项多中心随机对照预试验纳入89例(136条肢体)C3-C6慢性静脉疾病且既往依从性低的患者,比较ACTitouch装置与30-40 mmHg梯度压力袜。结果显示AT组在穿戴和脱下便捷性上显著优于压力袜,但舒适度无显著差异;两组依从性无显著差异。患者自报使用时间比装置客观记录高2.5小时,提示自报不可靠。

要点

  • AT装置在易穿脱方面显著优于压力袜,舒适度与压力袜相当。
  • 两组依从性无显著差异,但患者自报使用时间高估实际使用约2.5小时。
  • AT装置在低依从性患者中可达到与压力袜相当的接受度和依从性。

核心结论

  • 在C3-C6慢性静脉疾病且既往依从性低的患者中,AT装置在患者接受度和依从性方面与压力袜相当,临床结局可能相当或更优。

研究设计与样本

  • 两臂、随机、多中心预试验,纳入89例(136条肢体)原发性慢性静脉疾病(C3-C6)且既往依从性低的患者,随机分配至AT装置组(66条肢体)或30-40 mmHg梯度压力袜组(70条肢体)。

主要发现

  • AT组患者自报压缩使用时间平均比装置客观记录高2.5小时,一致性界限为-6至+11小时。

关键数值与推荐

  • 主要终点为患者报告的舒适度和易用性;次要终点包括依从性(装置计量器和患者日记)、肢体体积变化(水置换法和周径)以及疾病严重程度变化(VCSS、VEINES-QOL/Sym、EQ-5D-3L)。
  • 患者自报使用时间与装置记录的一致性界限为-6至+11小时,提示自报时间不可靠且倾向于高估实际使用。

临床怎么用

  • 对于既往依从性低的C3-C6慢性静脉疾病患者,AT装置可作为压力袜的替代选择,尤其在穿脱便捷性方面具有优势。
  • 临床评估中应警惕患者自报压缩治疗时间的可靠性,条件允许时使用客观计量装置。

局限性

  • 本研究为预试验,样本量有限(89例患者,136条肢体),结果需更大规模研究验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: The ACTitouch (AT) device (Tactile Medical, Minneapolis, Minn) represents a new generation of pneumatic compression devices by combining sustained compression with intermittent pneumatic compression. The sustained compression mode provides automatic pressure adjustment every 30 minutes, ensuring pressure consistency regardless of leg volume changes and environmental influences. Designed for mobile patients, this device has not been studied in comparison to standard compression stockings (CS). METHODS: A two-arm, randomized, multicenter pilot study was conducted. Patients with primary chronic venous disease (C3-C6) and a documented history of low adherence to compression therapy were randomized at 10 centers to use the AT device or 30 to 40 mm Hg graduated CS. Primary end points were patient-reported comfort and ease of use. Secondary end points included compliance (measured by a device meter and patient diaries), limb volume change (by water displacement and circumferences), and change in disease severity (using Venous Clinical Severity Score, Venous Insufficiency Epidemiological and Economic Study on Quality of Life/Symptoms, and EuroQol-5 Dimension 3-Level). Patients were assessed at 15 and 30 days after randomization. Eighty-nine patients (136 limbs) received either AT (66 limbs) or CS (70 limbs). RESULTS: Patients in the AT group found the device easy to apply (71% compared with 37.5% in the CS group; P = .0001), easy to remove (89% compared with 59% in the CS group; P = .0001), and comfortable to wear (71% compared with 58% in the CS group; P = .125). Compliance with compression was not significantly different between the groups (100% vs 88%, AT and CS groups, respectively, at 15 days; 87% vs 85% at the end of the study; P = .97). Daily use was not different either (10.7 hours in the AT group, 11.7 ± 2.7 hours in the CS group). In the AT group, in addition to self-reporting, the patient's compliance was objectively measured by a usage meter built into the device. The average time of compression use reported by patients was 2.5 hours higher than measured by the device, and the limits of agreement were -6 hours to +11 hours. These findings indicate that self-reported time of use is highly unreliable and tends to overestimate the actual use. CONCLUSIONS: This is the first trial comparing an adaptive pneumatic compression device with CS in previously noncompliant patients with C3 to C6 chronic venous disease. The study demonstrated that even within limitations of a pilot project, use of the AT device is comparable to CS in the patient's acceptance and compliance and likely to have equal or better clinical outcomes.

来源:J Vasc Surg Venous Lymphat Disord,查看原文。版权归原作者所有。

引用

  1. Lurie F, Schwartz M. Patient-centered outcomes of a dual action pneumatic compression device in comparison to compression stockings for patients with chronic venous disease. J Vasc Surg Venous Lymphat Disord. 2017. PMID: 28818225. doi:10.1016/j.jvsv.2017.06.003

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。